Omics

George Calin, Professor, Department of Experimental Therapeutics, and Co-Director, The Center for RNA Interference and Non-coding RNAs, MD Anderson Cancer Center, USA

To win the war on cancer, we need to put proteomics on an equal footing with genomics

Chiral amino acids are now under the spotlight as biomarkers for kidney disease

New biomarkers could predict cognitive decline in Parkinson's disease patients

Ultrasensitive mutation analysis could boost the potential of liquid biopsy

A genome-wide study shows that anorexia isn't purely psychiatric: metabolic factors also play a role

A test to profile intestinal microbiota could help diagnose inflammatory bowel disease

Can genetic home test kits ever be a good thing?

Protocols that allow multiple simultaneous -omic studies are the way of the future

What does analysis of the last 15 years of literature on the different omics tell us about the growing importance of the field